Alnylam Pharmaceuticals

United States
2,747 Total Employees
Year Founded: 2002
Alnylam is a biopharmaceutical company pioneering RNA interference (RNAi) therapeutics, a gene-silencing approach designed to treat disease by disabling genes that cause or contribute to it. The company discovers, develops, and commercializes medicines based on RNAi, including approved therapies and a pipeline of investigational treatments. Its research targets both rare and prevalent diseases, with a mission to bring innovative medicines to patients.

Recently Posted Jobs at Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Offices

Hybrid Workspace

Employees engage in a combination of remote and on-site work.

Typical time on-site:
United States